Requests that the FDA declare that Triamcinolone Acetonide Cream, 0.25 and 0.05, is suitable for submission as an ANDA. | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-5989

Requests that the FDA declare that Triamcinolone Acetonide Cream, 0.25 and 0.05, is suitable for submission as an ANDA.

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensMay 27, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Completeness Assessment Correspondence	Jul 2, 2026	--

Keywords

CDER

Suitability Petition

Hyman, Phelps & McNamara, P.C.

declare that

Triamcinolone Acetonide Cream, 0.25 and 0.05,

is suitable for submission as an ANDA.

As designated in FDA's

Approved Drug Products with

Data from Regulations.gov